Trials / Completed
CompletedNCT02904759
Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Male Subjects
A Randomised, Double-blind, Placebo-controlled, Multi-centre Trial Investigating the Efficacy and Safety of Desmopressin (FE 992026) Orally Disintegrating Tablets During 12 Weeks of Treatment for Nocturia Due to Nocturnal Polyuria in Japanese Male Subjects
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 342 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- Male
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this trial is to demonstrate efficacy of desmopressin ODT against placebo for the treatment of male subjects with nocturia due to nocturnal polyuria, during 12 weeks of treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Desmopressin | |
| DRUG | Placebo |
Timeline
- Start date
- 2016-09-01
- Primary completion
- 2017-09-29
- Completion
- 2017-09-29
- First posted
- 2016-09-19
- Last updated
- 2019-09-11
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02904759. Inclusion in this directory is not an endorsement.